Administration of Brincidofovir and Convalescent Plasma in a Patient With Ebola Virus Disease

Document Viewer

Share this page:

Title

Administration of Brincidofovir and Convalescent Plasma in a Patient With Ebola Virus Disease

Subject

Description

From 2014 to May 2015, >26 000 Ebola virus disease (EVD) cases were reported from West Africa.

Date Last Updated (Year-Month-Day)

2015-09-15

Citation

Florescu, D. F., A. C. Kalil, A. L. Hewlett, A. J. Schuh, U. Stroher, T. M. Uyeki and P. W. Smith (2015). "Administration of Brincidofovir and Convalescent Plasma in a Patient With Ebola Virus Disease." Clin Infect Dis 61(6): 969-973.

Abstract

From 2014 to May 2015, >26 000 Ebola virus disease (EVD) cases were reported from West Africa. We present a patient with EVD who received brincidofovir and convalescent plasma. The relative contributions of supportive care, investigational therapies, and patient's immune-response on survival could not be determined. Randomized trials are needed.

Accessibility

free online - Oxford Academic